A 3-year-old boy was found to have a mixed tubulopathy with hypokalemia (1.9 mmol/l), alkalosis (blood pH 7.51, plasma carbon dioxide pressure 46 mm Hg, plasma bicarbonate 35.7 mmol/l) and hypophosphatemia (1.21 mmol/l). An electrocardiogram disclosed a prolonged heart rate corrected QT interval of 490 ms. The boy was put on potassium chloride, phosphate and nonsteroidal anti-inflammatory agents. With this treatment plasma phosphate normalized and plasma potassium increased up to 3.0–3.3 mmol/l. Three years later the child, who did not have history of gastroesophageal reflux or epileptic convulsions, suddenly died during sleep. The cause of death could not be determined through gross examination of the body. The history of hypokalemia, the QT-prolongation, the sudden death and the failure to assess the cause of death through gross examination of the body suggest that death was caused by an arrhythmia secondary to hypokalemia.

Keywords:
Hypokalemia, Bartter’s disease, Sudden cardiac death
1.
Bettinelli A, Vezzoli G, Colussi G, Bianchetti MG, Sereni F, Casari G: Genotype-phenotype correlations in normotensive patients with primary renal tubular hypokalemic alkalosis. J Nephrol 1998;11:61–70.
2.
Rodríguez-Soriano J: Bartter and related syndromes: the puzzle is almost solved. Pediatr Nephrol 1998;12:315–327.
3.
Brem AS: Disorders of potassium homeostasis. Pediatr Clin North Am 1990;37:419–427.
4.
Li H, Fuentes-Garcias J, Towbin JA: Current concepts in long QT syndrome. Pediatr Cardiol 2000;21:542–550.
5.
Blomstrom-Lundqvist C, Caidahl K, Olsson SB, Rudin A: Electrocardiographic findings and frequency of arrhythmias in Bartter’s syndrome. Br Heart J 1989;61:274–279.
6.
Alon U, Hellerstein S: Assessment and interpretation of the tubular threshold for phosphate in infants and children. Pediatr Nephrol 1994;8:250–251.
7.
Sagie A, Larson MG, Goldberg RJ, Bengtson JR, Levy D: An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 1992;70:797–801.
8.
Rodríguez-Soriano J, Vallo A, Oliveros R: Bartter’s syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin. Helv Paediatr Acta 1978;33:141–151.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.